Related Experiment Video
Updated: May 14, 2026
29:13
Microbial Communities in Nature and Laboratory - Interview
Published on: May 28, 2007
[Genetic information and future medicine]
1Department of Medical Genetics, Shinshu University School of Medicine, Matsumoto 390-8621, Japan. aksakura@shinshu-u.ac.jp
Rinsho Byori. the Japanese Journal of Clinical Pathology
|February 7, 2013
Summary
Genetic testing advances disease understanding and treatment. Guidelines ensure appropriate genetic testing, protecting patients and families from psychological distress.
Area of Science:
- Genetics and Genomics
- Medical Diagnostics
Context:
- Technological advancements in genetic analysis are uncovering the genetic basis of diseases.
- Genetic information aids in disease management, targeted drug development, and early diagnosis of at-risk individuals.
Purpose:
- To outline the evolution and importance of genetic testing guidelines in Japan.
- To ensure appropriate genetic testing practices and protect patients and families.
Summary:
- Japanese guidelines for genetic testing were first released in 2003 and revised in 2011 by the Japanese Society of Medical Sciences.
- These guidelines address the clinical benefits of genetic analysis, including disease management and drug development, alongside the psychological impact on families.
Impact:
- Facilitates informed clinical decision-making regarding genetic testing.
- Promotes ethical and safe integration of genetic testing into healthcare practices.
- Supports healthcare professionals in navigating the complexities of genetic diagnostics and counseling.
More Related Videos
Related Concept Videos
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
00:49What is Genetic Engineering?
Overview
01:20The Central Dogma
The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...